Joel Isaacson & Co., LLC Dexcom Inc Transaction History

Joel Isaacson & Co., LLC

$2.07 Billion
Q3 2024

A detailed history of Joel Isaacson & Co., LLC transactions in Dexcom Inc stock. As of the latest transaction made, Joel Isaacson & Co., LLC holds 8,660 shares of DXCM stock, worth $694,878. This represents 0.03% of its overall portfolio holdings.

Number of Shares

8,660

Previous 8,660 -0.0%

Holding current value

$694,878

Previous $981,000 40.88%

% of portfolio

0.03%

Previous 0.05%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 26, 2023	SELL	$112.47 - $130.98 $25,305 - $29,470	-225 Reduced 2.53%	8,660 $1.11 Million
Q4 2022 Jan 27, 2023	BUY	$84.98 - $122.67 $177,183 - $255,766	2,085 Added 30.66%	8,885 $0
Q2 2022 Jul 15, 2022	BUY	$67.99 - $132.89 $346,749 - $677,738	5,100 Added 300.0%	6,800 $507,000
Q1 2022 Apr 21, 2022	SELL	$94.08 - $130.2 $564 - $781	-6 Reduced 0.35%	1,700 $817,000
Q4 2021 Jan 19, 2022	BUY	$129.87 - $162.82 $779 - $976	6 Added 0.35%	1,706 $916,000
Q2 2021 Jul 20, 2021	SELL	$80.99 - $107.93 $68,841 - $91,740	-850 Reduced 33.33%	1,700 $726,000
Q4 2020 Jan 22, 2021	SELL	$78.0 - $104.5 $39,000 - $52,250	-500 Reduced 16.39%	2,550 $943,000
Q2 2020 Jul 21, 2020	SELL	$62.68 - $105.34 $247,586 - $416,093	-3,950 Reduced 56.43%	3,050 $1.24 Million
Q4 2019 Jan 24, 2020	SELL	$36.62 - $57.29 $29,295 - $45,832	-800 Reduced 10.26%	7,000 $1.53 Million
Q3 2019 Oct 15, 2019	BUY	$35.53 - $43.8 $46,189 - $56,939	1,300 Added 20.0%	7,800 $1.16 Million
Q2 2019 Jul 11, 2019	SELL	$27.84 - $38.92 $55 - $77	-2 Reduced 0.03%	6,500 $974,000
Q4 2018 Jan 18, 2019	BUY	$26.99 - $37.37 $53 - $74	2 Added 0.03%	6,502 $917,000
Q1 2018 May 01, 2018	BUY	$13.06 - $18.54 $26,120 - $37,080	2,000 Added 44.44%	6,500 $482,000
Q3 2017 Nov 02, 2017	BUY	$11.36 - $18.98 $51,120 - $85,410	4,500	4,500 $220,000

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Joel Isaacson & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Joel Isaacson & Co., LLC with notifications on news.

Account

Joel Isaacson & Co., LLC Dexcom Inc Transaction History